Dixon et al. reported that iron chelator treatment induced tumor suppression by upregulating the metastasis suppressor NDRG1 in prostate cancer cells, and the overexpression of Ndrg1 induced an increase in the level of the tumor suppressor gene PTEN and decreased tumorigenic pAKT [126]. The gene discussed is PTEN; the disease is prostate cancer.